After moving 0.9% during today's afternoon session, Pfizer is now trading at a price of $32.98 per share. On average, analysts give it a target price of $44.38.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Pfizer Investors Should Consider This:
-
Pfizer has moved -23.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of -0.67. A number between 0 and 1 could mean that the market is undervaluing Pfizer's estimated growth potential
-
Its Price to Book (P/B) ratio is 1.88
-
Pfizer currently returns an annual dividend yield of 5.0%.
Understanding Pfizer's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 100,330,000 | -28,931,000 | 37 | 5.71 |
| 2022-02-24 | 81,288,000 | -21,885,000 | 35 | 75.0 |
| 2021-02-25 | 41,651,000 | -24,867,000 | 20 | 11.11 |
| 2020-02-27 | 40,905,000 | -25,540,000 | 18 | 12.5 |
| 2019-02-28 | 40,825,000 | -25,108,000 | 16 | -40.74 |
| 2018-02-22 | 52,546,000 | -27,199,000 | 27 |
Over the last 6 years, Pfizer's operating margins have averaged 25.5%, which is better than the 12.02% Pharmaceutical industry average. We also note that the company's operating margins have a high coefficient of variability at 35.1%. In addition, the firm's margins benefit from a 5.4% yearly growth rate.
